Prostate Cancer


ß-Carotene Supplementation for Patients with Low Baseline Levels and Decreased Risks of Total and Prostate Carcinoma
10-Year Outcome for Men with Localized Prostate Cancer Treated with External Radiation Therapy: Results of a Cohort Study.
A comparison of External Beam Radiation Therapy versus Radical Prostatectomy for Patients with Low Risk Prostate Carcinoma Diagnosed, Staged, and Treated at a Single Institution
A Prospective Study Of The Serum Prostate Specific Antigen Concentrations And Gleason Histologic Scores Of Black And White Men With Prostate Carcinoma
A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer
American Brachytherapy Society (ABS) Recommendations for Transperineal Permanent Brachytherapy of Prostate Cancer
Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer
Biochemical Failure does not Predict Overall Survival after Radical Prostatectomy for Localized Prostate Cancer: 10-year Results
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer
Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: A preliminary study
Combined Androgen Blockade with Nonsteroidal Antiandrogens for Advanced Prostate Cancer: A Systematic Review Comparative Efficiency of Prostate-Specific Antigen Screening Strategies for Prostate Cancer Detection
Comparison of Radiation Side-Effects of Conformal and Conventional Radiotherapy in Prostate Cancer: a Randomised Trial
Cost-Effectiveness of Androgen Suppression Therapies in Advanced Prostate Cancer
Detection of Prostate Cancer: Serendipity Strikes Again
Does Prolonged Combined Androgen Blockade Have Survival Benefits Over Short-Term Combined Androgen Blockade Therapy?
Extensive Biopsy Protocol Improves the Detection Rate of Prostate Cancer
Health Outcomes after Prostatectomy or Radiotherapy for Prostate Cancer: Results From the Prostate Cancer Outcomes Study
Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy andGoserelin
Intensity-Modulated Radiotherapy As Primary Treatment For Prostate Cancer: Acute Toxicity In 114 Patients
Laparoscopic Radical Prostatectomy: Preliminary Results
Long-Term Results Of A Randomized Trial For The Treatment Of Stages B2 And C Prostate Cancer: Radical Prostatectomy Versus External Beam Radiation Therapy With A Common Endocrine Therapy In Both Modalities
Osteoporosis in men treated with androgen deprivation therapy for prostate cancer
Percentage of Free PSA in Black versus White Men for Detection and Staging of Prostate Cancer: A Prospective Multicenter Clinical Trial
Post-treatment PSA </= 0.2 ng/mL Defines Disease Freedom After Radiotherapy for Prostate Cancer Using Modern Techniques
Prostate Cancer And Supplementation With Alpha-Tocopherol And Beta-Carotene: Incidence And Mortality In A Controlled Trial
Prostate cancer in African-American men: Outcome following radiation therapy with or without adjuvant androgen ablation
Prostate Specific Antigen Bounce after Radioactive Seed Implantation Followed by External Beam Radiation for Prostate Cancer
Radiation Therapy for Clinically Localized Prostate Cancer: A Multi-Institutional Pooled Analysis
Radical Surgery versus Radiotherapy for Adenocarcinoma of the Prostate
Second Primary Tumors after Prostate Carcinoma
Seminal Vesicle-Sparing Radical Prostatectomy: A Novel Concept to Restore Early Urinary Continence
Significance of the CAG Repeat Polymorphism of the Androgen Receptor Gene in Prostate Cancer Progression
Six-month Androgen Suppression Plus Radiation Therapy vs. Radiation Therapy Alone for Patients with Clinically Localized Prostate Cancer
Six-month Androgen Suppression Plus Radiation Therapy vs. Radiation Therapy Alone for Patients with Clinically Localized Prostate Cancer
Temporarily Deferred Therapy (watchful waiting) for Men Younger Than 70 Years and With Low-Risk Localized Prostate Cancer in the Prostate-Specific Antigen Era
Testosterone Recovery Following Prolonged Adjuvant Androgen Ablation for Prostate Carcinoma
The bicalutamide Early Prostate Cancer Program. Demography
The Effect of Androgen Deprivation on the Early Changes in Prostate Volume Following Transperineal Ultrasound Guided Interstitial Therapy for Localized Carcinoma of the Prostate
The Role of Androgen Deprivation in the Definitive Management of Clinically Localized Prostate Cancer Treated with Radiation Therapy
Therapeutic Radiation in Patients With a Rising Post-Prostatectomy PSA Level
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
Urinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate Cancer